Peptides for Longevity & Biohacking Research

Longevity research has identified several hallmarks of aging that peptides can target. NAD+ decline is now recognised as a central driver of aging — it impairs mitochondrial function, reduces sirtuin activity (the longevity enzymes), and compromises DNA repair. GHK-Cu has been shown in genomic studies to reset the expression of over 4,000 genes towards youthful patterns, including genes involved in DNA repair, antioxidant defence, and tissue remodelling. Glutathione levels also decline with age, leaving cells vulnerable to oxidative damage that accelerates every aspect of aging. Together, these compounds address multiple hallmarks of aging simultaneously — the approach favoured by leading longevity researchers.

Sirtuins are a family of seven NAD+-dependent enzymes (SIRT1-7) that regulate cellular processes critical to longevity: DNA repair, mitochondrial biogenesis, inflammatory gene silencing, and metabolic efficiency. They are often called longevity genes because their activation in model organisms consistently extends lifespan. However, sirtuins require NAD+ as a fuel — without adequate NAD+, they cannot function. This is why NAD+ decline with age effectively silences the body's longevity programme. Peptides Pharma's NAD+ and NAD+ vial pens provide direct bioavailable NAD+ to keep sirtuins active, bypassing the inefficient conversion from precursors like NMN or nicotinamide riboside.

GHK-Cu is remarkable among peptides for its ability to broadly influence gene expression. A landmark study by Pickart and colleagues using the Connectivity Map database showed that GHK-Cu modulates 31.2% of human genes, with a clear pattern of upregulating genes associated with youthful tissue function and downregulating genes associated with aging and disease. Specifically, it increases expression of collagen, elastin, and glycosaminoglycan genes, DNA repair enzymes, antioxidant genes including superoxide dismutase and Glutathione-related enzymes, and nerve growth factors — while suppressing genes linked to inflammation, fibrosis, and metastasis. This comprehensive gene-level remodelling makes GHK-Cu uniquely valuable for longevity research.

Modern biohacking protocols typically involve systematic combination of compounds targeting different aging hallmarks. A research-grade longevity stack might include daily NAD+ via the NAD+ vial system for sirtuin activation and mitochondrial support, GHK-Cu for gene expression remodelling and tissue maintenance, and Glutathione for antioxidant defence and detoxification. These peptides are often studied alongside lifestyle interventions including time-restricted eating (which also elevates NAD+ and activates sirtuins), cold exposure, and exercise — all of which share overlapping molecular pathways. Peptides Pharma's vial systems make precise, consistent dosing straightforward for long-term research protocols.